Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuro Onitsuka

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Japanese Journal of Clinical Oncology|November 26, 2014
Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancerTomoya Yokota, Tsuyoshi Onoe, Hirofumi Ogawa, et al.
Gastrointestinal Endoscopy|April 2, 2013
Feasibility of a "resect and watch" strategy with endoscopic resection for superficial pharyngeal cancerKenichiro Imai, Masaki Tanaka, Noriaki Hasuike, et al.
Japanese Journal of Clinical Oncology|April 22, 2017
Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3Masahiro Kawahira, Tomoya Yokota, Satoshi Hamauchi, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 18, 2008
Dedifferentiated epithelial-myoepithelial carcinoma of the parotid gland: a rare case report of immunohistochemical analysis and review of the literatureKimihide Kusafuka, Yoshinori Takizawa, Takao Ueno, et al.
International Journal of Clinical Oncology|March 7, 2013
Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?Tomoya Yokota, Tetsuro Onitsuka, Kimihide Kusafuka, et al.
International Journal of Clinical Oncology|October 18, 2019
Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neckHidenori Kimura, Satoshi Hamauchi, Sadayuki Kawai, et al.
Annals of Surgical Oncology|October 8, 2016
Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal CancerKatsushi Takebayashi, Yasuhiro Tsubosa, Tomoyuki Kamijo, et al.
Molecular and Clinical Oncology|August 18, 2020
Feasibility and efficacy of chemoradiotherapy with concurrent split-dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for locally advanced head and neck cancerTomoya Yokota, Masayuki Shibata, Satoshi Hamauchi, et al.
International Journal of Clinical Oncology|January 19, 2019
Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatinSatoshi Hamauchi, Tomoya Yokota, Takatsugu Mizumachi, et al.
International Journal of Clinical Oncology|March 8, 2021
Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful?Tomoya Yokota, Tetsuro Onitsuka, Satoshi Hamauchi, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Japanese Journal of Clinical Oncology|November 26, 2014
Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancerTomoya Yokota, Tsuyoshi Onoe, Hirofumi Ogawa, et al.
Gastrointestinal Endoscopy|April 2, 2013
Feasibility of a "resect and watch" strategy with endoscopic resection for superficial pharyngeal cancerKenichiro Imai, Masaki Tanaka, Noriaki Hasuike, et al.
Japanese Journal of Clinical Oncology|April 22, 2017
Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3Masahiro Kawahira, Tomoya Yokota, Satoshi Hamauchi, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 18, 2008
Dedifferentiated epithelial-myoepithelial carcinoma of the parotid gland: a rare case report of immunohistochemical analysis and review of the literatureKimihide Kusafuka, Yoshinori Takizawa, Takao Ueno, et al.
International Journal of Clinical Oncology|March 7, 2013
Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?Tomoya Yokota, Tetsuro Onitsuka, Kimihide Kusafuka, et al.
International Journal of Clinical Oncology|October 18, 2019
Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neckHidenori Kimura, Satoshi Hamauchi, Sadayuki Kawai, et al.
Annals of Surgical Oncology|October 8, 2016
Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal CancerKatsushi Takebayashi, Yasuhiro Tsubosa, Tomoyuki Kamijo, et al.
Molecular and Clinical Oncology|August 18, 2020
Feasibility and efficacy of chemoradiotherapy with concurrent split-dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for locally advanced head and neck cancerTomoya Yokota, Masayuki Shibata, Satoshi Hamauchi, et al.
International Journal of Clinical Oncology|January 19, 2019
Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatinSatoshi Hamauchi, Tomoya Yokota, Takatsugu Mizumachi, et al.
International Journal of Clinical Oncology|March 8, 2021
Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful?Tomoya Yokota, Tetsuro Onitsuka, Satoshi Hamauchi, et al.
Pageof 7